Revolade 50mg 28 TABLET
Revolade 50mg Tablets
Revolade 50mg tablets are a specialized medication containing the active ingredient Eltrombopag. It is primarily used to increase the number of platelets in your blood. This is crucial for individuals with chronic immune (idiopathic) thrombocytopenia (ITP) when other treatments have not been effective enough. It is also prescribed for adults with chronic hepatitis C virus (HCV) infection who have low platelet counts to enable them to receive or continue interferon-based antiviral therapy. Furthermore, Revolade is indicated for the treatment of severe aplastic anemia (SAA).
Benefits of Use
Revolade offers significant benefits for patients:
- Increases platelet count, thereby reducing the risk of bleeding episodes and bruising.
- Allows patients with chronic HCV to safely undergo or continue essential antiviral treatments that might otherwise be halted due to low platelet counts.
- Improves hematologic response in patients with severe aplastic anemia.
- Enhances quality of life by managing conditions associated with low platelet counts.
How to Use
Always follow your doctor's instructions precisely when taking Revolade 50mg tablets.
- Take Revolade on an empty stomach.
- Swallow the tablet whole with a glass of water.
- Ensure you take Revolade at least four hours before or after consuming any products high in calcium (e.g., dairy products, calcium-fortified juices).
- Avoid taking antacids, mineral supplements containing polyvalent cations (such as iron, calcium, magnesium, aluminum, selenium, and zinc), or other products containing these cations within four hours of taking Revolade.
- Your doctor will determine the appropriate dose and duration of treatment based on your condition and platelet count.
- Do not stop taking Revolade without consulting your doctor, as platelet counts may drop significantly.
Caution & Warnings
Before taking Revolade, discuss all medical conditions and medications with your healthcare provider.
- Liver Function Monitoring: Revolade can affect liver function. Regular blood tests to monitor liver enzymes are necessary during treatment.
- Risk of Blood Clots: There is an increased risk of developing blood clots, especially if your platelet count becomes too high.
- Bone Marrow Changes: Changes in the bone marrow and risk of worsening myelodysplastic syndrome (MDS) in some patients.
- Cataracts: Some patients may develop cataracts. Regular eye examinations may be recommended.
- Gastrointestinal Issues: Common side effects include nausea, diarrhea, and abdominal pain.
- Bleeding Risk: Do not discontinue treatment abruptly, as this may lead to a rebound decrease in platelet count and increased risk of bleeding.
- Pregnancy and Breastfeeding: Revolade is not recommended during pregnancy or breastfeeding unless clearly necessary and advised by a doctor.
- Children: The safety and effectiveness in children for some indications may vary.
Ingredients
Active Ingredient: Eltrombopag (as eltrombopag olamine).
Excipients: (Specific excipients may vary by formulation but typically include) Microcrystalline cellulose, magnesium stearate, povidone, sodium starch glycolate, mannitol, and film coating components.
Product Details
- Product Type: Prescription Medication
- Form: Oral Tablets
- Strength: 50mg per tablet
- Package Size: 28 Tablets
- Manufacturer: Novartis
- Principle: Eltrombopag
| Gtin | 9-665-16 |
|---|---|
| Recommended Sale Price | 4939.7 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| SFDA Reg. No | 9-665-16 |
| IBC | 9-665-16 |
| Drug Type | Prescription |
| Scientific Name | Eltrombopag |
| Strength | 50mg |
| Strength Unit | mg |
| Form | Tablet |
| Admin Route | Oral |
| Size | 28 |
| Size Unit | Tablet |
| Package Types | Blister Pack |
| Package Size | 28 Tablets |
| Storage conditions | Store below 30°C. Protect from moisture. |
| Refrigerator Storage | No |
